Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-02 Sale | 2023-06-02 7:15 pm | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie Chief Financial Officer | 4,647 | $37.06 | $172,218 | 80,015 (Direct) | View |
| 2023-05-24 Sale | 2023-05-24 7:38 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer | 619 | $45.29 | $28,035 | 124,123 (Direct) | View |
| 2023-01-18 Sale | 2023-01-20 09:20 am | Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director | 2,546 | $44.66 | $113,704 | 0 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 09:45 am | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 3,179 | $42.38 | $134,715 | 61,792 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 09:45 am | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 2,245 | $42.38 | $95,142 | 97,878 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 09:45 am | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 1,566 | $42.38 | $66,366 | 47,223 (Direct) | View |
| 2023-01-09 Sale | 2023-01-10 5:00 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,088 | $45.37 | $94,733 | 48,789 (Direct) | View |
| 2023-01-04 Sale | 2023-01-05 5:13 pm | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 3,648 | $46.6 | $169,997 | 168,777 (Direct) | View |
| 2023-01-04 Sale | 2023-01-05 5:13 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 1,949 | $46.6 | $90,823 | 100,123 (Direct) | View |
| 2022-12-21 Sale | 2022-12-21 9:21 pm | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 9,092 | $40.42 | $367,469 | 172,425 (Direct) | View |
| 2022-12-21 Sale | 2022-12-21 9:20 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 3,248 | $40.41 | $131,266 | 50,877 (Direct) | View |
| 2022-12-21 Sale | 2022-12-21 9:20 pm | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 4,616 | $40.41 | $186,552 | 64,971 (Direct) | View |
| 2022-12-16 Sale | 2022-12-20 4:02 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 2,410 | $43 | $103,624 | 102,072 (Direct) | View |
| 2022-12-02 Sale | 2022-12-05 5:00 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 1,726 | $90.19 | $155,667 | 104,482 (Direct) | View |
| 2022-11-28 Sale | 2022-11-28 7:01 pm | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 69,256 | $100 | $6,925,600 | 197,157 (Direct) | View |
| 2022-08-12 Sale | 2022-08-16 4:15 pm | Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director | 10,000 | $85.49 | $854,899 | 6,021 (Direct) | View |
| 2022-05-23 Sale | 2022-06-14 4:35 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 624 | $63.54 | $39,649 | 86,804 (Direct) | View |
| 2022-02-11 Sale | 2022-02-14 4:51 pm | Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director | 11,000 | $105.61 | $1,161,717 | 6,021 (Direct) | View |
| 2022-01-19 Sale | 2022-01-20 4:57 pm | Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director | 1,475 | $116.07 | $171,203 | 2,546 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 8:34 pm | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 533 | $120.48 | $64,217 | 24,279 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 8:33 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 627 | $120.51 | $75,558 | 105,249 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 8:32 pm | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 2,517 | $120.48 | $303,253 | 348,276 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-20 Option Award | 2023-01-24 4:20 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director 10% Owner | 11,964 | $0 | 55,037 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:20 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 11,964 | $0 | 180,741 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:19 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director | 11,964 | $0 | 17,985 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:18 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director | 11,964 | $0 | 11,964 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:17 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director | 17,049 | $0 | 25,766 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:03 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 11,964 | $0 | 16,934 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 72,320 | $0 | 170,198 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 240,612 | $0 | 302,404 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 81,850 | $0 | 129,073 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director | 11,964 | $0 | 17,985 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO | 72,320 | $0 | 130,118 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director | 11,964 | $0 | 17,985 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:00 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director | 11,964 | $0 | 17,985 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 9:21 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 53,618 | $0 | 172,425 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 9:20 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 19,149 | $0 | 50,877 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 9:20 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer | 35,425 | $0 | 64,971 (Direct) | View |
| 2022-11-28 Exercise | 2022-11-28 7:01 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 69,256 | $17.41 | 197,157 (Direct) | View |
| 2022-11-28 Exercise | 2022-11-28 7:01 pm | N/A 2024-05-20 | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 69,256 | $0 | 197,157 (Direct) | View |
| 2022-11-07 Option Award | 2022-11-08 6:00 pm | N/A 2032-11-06 | Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:35 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 19,149 | $0 | 106,089 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 4:15 pm | N/A 2028-01-17 | Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director | 10,000 | $0 | 6,021 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 4:15 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director | 10,000 | $27 | 6,021 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 5:56 pm | N/A 2032-05-31 | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO | 148,962 | $0 | 148,962 (Direct) | View |
Ownership | 2022-05-16 5:01 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO | 0 | $0 | 0 (Direct) | View |
| 2022-02-11 Exercise | 2022-02-14 4:51 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director | 11,000 | $20.54 | 6,021 (Direct) | View |
| 2022-02-11 Exercise | 2022-02-14 4:51 pm | 2017-09-09 2024-09-08 | Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director | 11,000 | $0 | 6,021 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 8:34 pm | N/A 2032-01-13 | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 14,287 | $0 | 24,279 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 8:33 pm | N/A 2032-01-13 | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer | 28,576 | $0 | 105,249 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 8:32 pm | N/A 2032-01-13 | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 67,868 | $0 | 348,276 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-18 8:32 pm | N/A 2028-01-17 | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 3,703 | $0 | 348,276 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-18 8:32 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D | 3,703 | $27 | 348,276 (Direct) | View |